1Yanagisawa M, Kurihara H, Kimura Set al. 1988. A novel potent vasoconstrictor peptide produced by Vascular endothelial cells. Nature, 332(6163) : 411 -415
3Inoue A, Yanagisawa M, Kimura S et al. 1989. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proceedings of the National Academy of Sciences of the United States of America, 86 ( 8 ) :2863 - 2867
4Johnstrom P, Fryer TD, Riehards HK et al. 2005. Positron emission tomography using 18F- labelled endothelin -1 reveals prevention of binding to cardiac receptors owing to tissue - specific clearance by ETB receptors in vivo. British Journal of Pharmacology, 144 ( 1 ) : 115 -122
5Williams DL Jr, Jones KL, Colton CD et al. 1991. Identification of high affinity endothelin - 1 receptor subtypes in human tissies. Biochemical anti Biophysical Research Communications, 180 ( 2 ) : 475 - 480
6Honore JC, Fecteau MH, Brochu Iet al. 2005. Concomitant antagonism of endothelial and vascular smooth muscle cell - ETB receptors for endothelin induces hypertension in the hamster. American Journal of Physiology- Heart and Circulatory Physiology, 289 (3): H1258 - H1264
7Goddard J, Johnston NR, Hand MF et al. 2004. Endothelin - A receptor antagonism reduces blood pressure and increases renal blood flow in hypertensive patients with chronic renal failure:a comparison of selective and combined endothelin receptor blockade. Circulation, 109(9) : 1186-1193
8Brenner F, Opie LH. 1998. Role of endothelin - A receptors in ischemic contracture mid reperfusion injury. Circulation, 97 ( 4 ) : 391 - 398
9Masaki T, Kimura S, Yanagisawa M et al. 1991. Molecular and cellular mechanism of endothelin regulation. Implications for vascular function. Circulation, 84(4) : 1457 - 1468
10Duru F, Barton M, Luseher TF et al. 2001. Endothelin and cardiac arrhythmias:do endothelin antagonists have a therapeutic potential as antiarrhythmic drugs? Cardiovascular Research, 49 ( 2 ) : 272- 280
